THURSDAY, SEPTEMBER 21, 2017

GenVec teaming up with Washington University on creating targeted adenovector-based therapeutics and vaccines

GenVec, Inc. said Wednesday it is partnering with Dr. David T. Curiel and his team at the School of Medicine at Washington University in St. Louis to develop new, highly targeted, adenovector-based therapeutics and vaccines. Read More »

Protein Sciences gets 12-year FDA exclusivity on Flublok flu vaccine

Protein Sciences Corp. said on Wednesday that the Food and Drug Administration (FDA) has granted exclusivity to Protein Sciences' Flublok influenza vaccine for 12 years. This exclusivity status means the FDA won't approve any similar product before Jan. 16, 2025. This is a rare move for the FDA, as Flublok is the first vaccine ever to be awarded this exclusivity status, suggesting that the new influenza vaccine may be the most unique and innovative to date. Read More »

VBI provides update on hepatitis C vaccine research at conference

VBI Vaccines recently presented the latest data about its eVLP platform being used in creating a new hepatitis C vaccine candidate at the World Vaccine Congress Asia, held Wednesday and Thursday at the Suntec Singapore Convention & Exhibition Centre in Singapore. Read More »

WHO, South Korea fight MERS-CoV outbreak

World Health Organization will help gather data on outbreak of Middle East Respiratory syndrome coronavirus Read More »

Conn. pathologist creates accurate detection method for Ebola

Sin Hang Lee's method involves a nested RT-PCR method. Read More »

New research may improve HIV vaccines

A new scientific discovery, made by researchers at Sanford-Burnham Medical Research Institute, may significantly change how health professionals prevent HIV infections. Read More »

St. Michael's Hospital finds successful new flu treatment

A team of researchers at St. Michael’s Hospital, located in Toronto, Ontario, have found a successful new treatment for the flu virus in mouse subjects, when the scientists treat the host rather than the virus itself. Read More »

Latest Indiana HIV outbreak report: 163 confirmed cases

The latest report from Indiana state health officials on the HIV outbreak provides a current total of 163 confirmed HIV cases in southeastern Indiana, plus three more cases with positive preliminary test results. Health care workers are providing services in the Austin Community Outreach Center, 2277 W Frontage Road, Austin, Indiana. Read More »

CDC reports Shigellosis cases in the U.S.

The Centers for Disease Control and Prevention (CDC) recently received new reports that there are Shigella infections from the Shigella strains that are not susceptible to the common antimicrobial agents (ciprofloxacin and azithromycin) used to treat the infections. Read More »

Most of Kyrgyzstan vaccinated against measles, rubella amid outbreak

Almost the entire population of Kyrgyzstan has been vaccinated against measles and rubella, Oleg Gorin, the nation's deputy minister of health and chief sanitary doctor, said last week. Since the beginning of the year, approximately 20,670 suspected measles cases were reported in Kyrgyzstan. The vaccination campaign was conducted nationally so that the country can stabilize its health and contain the outbreak. Read More »

Scientists discover how bacteria survive antibiotics

A recent discovery of how bacteria survive antibiotic treatments may help researchers discover an improved treatment method for infectious diseases. Read More »

Spotlight Innovation completes Memcine Pharmaceuticals acquisition

Spotlight Innovation, based in West Des Moines, Iowa, said on Monday that it has completed the acquisition of a majority ownership in Memcine Pharmaceuticals, based at the University of Iowa-Coralville. Memcine is currently creating a new vaccine platform technology called Immunoplex, which will use the body’s natural defenses as a carrier of vaccine components. Read More »

Malaria Consotium members hone communication message in Gambia

The Gambia Ministry of Health and Social Welfare, the National Malaria Control Programme (NMCP), and members of the Malaria Consortium recently conducted a behavioral change communication message development workshop before applying seasonal malaria chemoprevention (SMC). Read More »

Richard Benjamin named chief medical officer of Cerus Corp.

Cerus Corp. named Dr. Richard Benjamin, M.D, its new chief medical officer on Monday.Benjamin previously worked at the American Red Cross as chief medical officer. While there, he supervised patient and donor safety issues involving blood transfusion and collection. Read More »

Researchers test shingles virus treatments using embryonic stem cells

A team of scientists from Bar-Ilan University recently discovered that human embryonic stem cells are useful for testing drug treatments against varicella-zoster, also known as the chickenpox virus. The red rash that is a sign of chickenpox typically disappears with a week or two, but even though the rash is gone, the infection stays dormant within the body’s nervous system. Read More »

West African Ebola strain less aggressive than prototype strain from 1976

According to a recent report from the National Institutes of Health (NIH), the current strain of the Ebola virus that is circulating through West Africa is called the Makona strain and is less aggressive than the original Mayinga strain that, which was isolated in Central Africa in 1976. Read More »

AMA encourages stricter vaccination opt outs

Doctors suggest limiting exemptions to medical reasons only. Read More »

WHO partners refocus on how to measure country health program impact

WHO, World Bank and USAID agree accurate and timely health are foundation to improving public health. Read More »

Cellular Biomedicine Group acquires lung-cancer vaccine

Cellular Biomedicine Group (CBMG), a biomedicine firm that creates new treatments for cancerous and degenerative diseases, said on Tuesday that the company has finalized its acquisition of the CD40LGVAX lung-cancer vaccine and its related technologies and techniques, which will be implemented in a potential clinical trial.The GVAX vaccine was purchased for $2.5 million in cash and $1.75 million in CBMG common shares from Blackbird Bio Finance University in South Florida, which owns the license. Read More »

Nanotherapy used to further advance Type 1 Diabetes vaccine

A recent article described a new step forward in developing a vaccine to prevent Type 1 Diabetes onset, using nanotherapy technology. Read More »